Allarity Therapeutics Provides Update on Dovitinib Program
Go back to Allarity Therapeutics Provides Update on Dovitinib Program| (NASDAQ: ALLR) | Delayed: 1.41 +0.02 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.39 | 52 Week High | $ | |||
| Open | $1.41 | 52 Week Low | $ | |||
| Day High | $1.42 | P/E | N/A | |||
| Day Low | $1.35 | EPS | $ | |||
| Volume | 69,643 | |||||

